ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,668Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 1692

$1.24M Total Retail Price of All Prescriptions

Rank: 19 out of 1692

1,070 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,070 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 1,070 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 21,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 1,166 939 1 1
FUROSEMIDE 1,018 879 2 7
LISINOPRIL 920 774 3 2
LEVOTHYROXINE SODIUM 805 718 4 4
OMEPRAZOLE 729 619 5 5
METOPROLOL TARTRATE 606 489 6 10
WARFARIN SODIUM 595 513 7 14
TRAMADOL HCL 566 446 8 16
HYDROCODONE-ACETAMINOPHEN 532 309 S3 9 6
DONEPEZIL HCL 526 526 10 29
METFORMIN HCL 516 420 11 8
ATENOLOL 507 442 12 15
TRAZODONE HCL 460 333 13 33
AMLODIPINE BESYLATE 436 392 14 3
NAMENDA 428 428 15 50
CITALOPRAM HBR 424 377 16 21
PRAVASTATIN SODIUM 420 357 17 12
HYDROCHLOROTHIAZIDE 417 317 18 9
CARVEDILOL 326 298 19 24
GLIPIZIDE 309 243 20 47
PANTOPRAZOLE SODIUM 293 241 21 39
QUETIAPINE FUMARATE 254 239 22 62
MELOXICAM 253 210 23 41
SERTRALINE HCL 227 167 24 22
NEXIUM 226 157 25 25
MIRTAZAPINE 224 200 26 53
FAMOTIDINE 217 190 27 86
GABAPENTIN 213 153 28 13
ATORVASTATIN CALCIUM 213 184 28 11
RANITIDINE HCL 212 154 30 28
ALLOPURINOL 207 197 31 30
LANTUS 206 154 32 57
PREDNISONE 192 161 33 35
LOVASTATIN 186 163 34 37
CYCLOBENZAPRINE HCL 175 75 R 35 54
PROAIR HFA 175 107 35 40
FLUTICASONE PROPIONATE 174 134 37 27
CRESTOR 166 126 38 26
GLIMEPIRIDE 158 139 39 32
CLOPIDOGREL 154 124 40 43
ALENDRONATE SODIUM 153 132 41 36
ADVAIR DISKUS 150 126 42 45
BENAZEPRIL HCL 150 140 42 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 130 42 19
KLOR-CON M20 149 142 45 48
LOSARTAN POTASSIUM 148 132 46 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 143 117 47 100
TAMSULOSIN HCL 141 110 48 31
AMITRIPTYLINE HCL 136 98 R 49 58
SEROQUEL 130 123 50 130
NOVOLIN 70-30 122 87 51 249
AZITHROMYCIN 119 89 52 34
CIPROFLOXACIN HCL 119 108 52 65
ZOLPIDEM TARTRATE 119 87 52 23
TRIAMCINOLONE ACETONIDE 115 93 55 105
INSULIN SYRINGE 108 75 56 93
PLAVIX 106 91 57 66
MECLIZINE HCL 105 91 58 124
LANSOPRAZOLE 105 105 58 133
CLONIDINE HCL 105 95 58 46
GLYBURIDE 103 102 R 61 82
BUSPIRONE HCL 102 102 62 122
METOPROLOL SUCCINATE 101 90 63 18
ESCITALOPRAM OXALATE 99 96 64 76
ISOSORBIDE MONONITRATE ER 96 63 65 55
NYSTATIN 93 81 66 150
SPIRONOLACTONE 91 74 67 74
JANUVIA 91 86 67 72
BACLOFEN 91 30 67 115
RAMIPRIL 89 81 70 108
AMLODIPINE BESYLATE-BENAZEPRIL 89 84 70 67
NIFEDIPINE ER 83 72 72 114
HUMULIN 70-30 83 65 72 228
IPRATROPIUM-ALBUTEROL 83 66 72 155
VENLAFAXINE HCL ER 82 16 75 84
CELEBREX 81 50 76 103
PAROXETINE HCL 80 64 77 60
SPIRIVA 80 65 77 44
COLCRYS 79 74 79 154
AMOXICILLIN 79 66 79 95
LOSARTAN-HYDROCHLOROTHIAZIDE 78 61 81 38
GLYBURIDE-METFORMIN HCL 78 54 R 81 157
AGGRENOX 76 76 83 193
DICLOFENAC SODIUM 76 54 83 75
DILTIAZEM 24HR CD 76 76 83 96
DIOVAN 75 74 86 42
SINGULAIR 75 45 86 79
BUPROPION XL 74 51 88 235
LABETALOL HCL 71 71 89 207
DILTIAZEM 24HR ER 71 55 89 134
DIGOXIN 71 71 89 85
FLUOXETINE HCL 70 25 92 52
PROBENECID-COLCHICINE 69 42 93 333
NOVOLOG 66 55 94 120
ALBUTEROL SULFATE 66 55 94 115
HUMALOG 65 54 96 178
LEVOFLOXACIN 64 56 97 113
CARTIA XT 64 61 97 331
CEPHALEXIN 63 56 99 89
TRILIPIX 62 50 100 198
METFORMIN HCL ER 62 51 100 49
POTASSIUM CHLORIDE 62 56 100 20
SYNTHROID 60 55 103 59
HYDRALAZINE HCL 60 54 103 92
DOXAZOSIN MESYLATE 60 44 103 83
NITROFURANTOIN MONO-MACRO 59 51 106 226
PROMETHAZINE HCL 59 33 R 106 81
DOXYCYCLINE HYCLATE 59 54 106 126
TRIAMTERENE-HCTZ 57 34 109 61
FENOFIBRATE 55 54 110 63
ENALAPRIL MALEATE 55 55 110 71
OXYBUTYNIN CHLORIDE ER 54 52 112 152
MUPIROCIN 53 51 113 167
CALCITONIN-SALMON 52 42 114 345
DIVALPROEX SODIUM 52 22 114 97
CYMBALTA 52 0 114 51
TRANDOLAPRIL 51 51 117 306
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.